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Abstract 
Co-inheritance of α-thalassemia with homozygosity or compound heterozygosity for β-
thalassemia may ameliorate β-thalassemia major. A wide range of clinical phenotypes is 
produced depending on the number of α-thalassemia alleles (-α/αα --/αα, --/-α). The co-
inheritance of β-thalassemia with α-thalassemia with a single gene deletion (-α/αα) is usually 
associated with thalassemia major. In contrast, the co-inheritance of β-thalassemia with two 
α-genes deleted in cis or trans (--/αα or -α/-α) generally produces β-thalassemia intermedia. 
In Southeast Asia, the most common defect responsible for α-thalassemia is the Southeast 
Asian (SEA) deletion of 20.5 kilobases. The presence of the SEA deletion with Hb Constant 
Spring (HbCS) produces HbH-CS disease. Co-inheritance of HbH-CS with compound 
heterozygosity for β-thalassemia is very rare. This study presents a Malay patient with HbH-
CS disorder and β° /β +-thalassemia. The SEA deletion was confirmed in the patient using a 
duplex-PCR. A Combine-Amplification Refractory Mutation System (C-ARMS) technique to 
simultaneously detect HbCS and Hb Quong Sze confirmed HbCS in the patient. Compound 
heterozygosity for CD41/ 42 and Poly A was confirmed using the ARMS. This is a unique 
case as the SEA α-gene deletion in cis (-- SEA/αα) is generally not present in the Malays, 
who more commonly posses the two α-gene deletion in trans (-α/-α). In addition, the β-globin 
gene mutation at CD41/42 is a common mutation in the Chinese and not in the Malays. The 
presence of both the SEA deletion and CD41/42 in the mother of the patient suggests the 
possible introduction of these two defects into the family by marriage with a Chinese.  
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